Clinical trial
Relapse and Functional Outcomes in Anti-LGI1 Encephalitis: A Multicenter Study
NCT07722286 is registered in ClinicalTrials.gov with Shen Chun-Hong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relapse and Functional Outcomes in Anti-LGI1 Encephalitis: A Multicenter Study
- Lead sponsor
- Shen Chun-Hong
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- January 1, 2026
- Enrollment
- 112 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune encephalitis, lgi1 encephalitis, limbic encephalitis